News
Mursla Bio introduces AI Precision Medicine Platform built on organ-specific EV isolation from blood
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly ...
Evosep, a global leader in robust, high-throughput proteomics technologies, has been selected as the proteomics platform ...
A new ICES study has found that 1.74 million patients in Ontario are attached to family physicians aged 65 or older, and that ...
Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, today ...
What if people could detect cancer and other diseases with the same speed and ease of a pregnancy test or blood glucose meter ...
Liver transplant is a lifesaving surgery, but a significant number of patients experience organ rejection or other ...
Nearly two-thirds of adults oppose President Donald Trump's "One Big Beautiful Bill" approved in May by the House of ...
Bladder tumors that have been excluded from clinical trials have a few things in common that could lead to new therapies.
Earlier this month, the most recent team-building event saw the Bedfont ® office close for the afternoon, and staff were ...
GLP-1 drugs show promise in diabetes management, offering heart and kidney benefits, but also highlight the need for ...
A new grant from the National Institutes of Health (NIH) will help Wayne State University researchers explore potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results